249 related articles for article (PubMed ID: 24372235)
1. Nanoparticle-based tumor theranostics with molecular imaging.
Wang L; Wang Y; Li Z
Curr Pharm Biotechnol; 2013; 14(7):683-92. PubMed ID: 24372235
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
[TBL] [Abstract][Full Text] [Related]
4. Cancer nanotheranostics: Strategies, promises and impediments.
Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles in oncology: the new theragnostic molecules.
Allegra A; Penna G; Alonci A; Rizzo V; Russo S; Musolino C
Anticancer Agents Med Chem; 2011 Sep; 11(7):669-86. PubMed ID: 21787275
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
8. Challenges to effective cancer nanotheranostics.
Melancon MP; Stafford RJ; Li C
J Control Release; 2012 Dec; 164(2):177-82. PubMed ID: 22906841
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
[TBL] [Abstract][Full Text] [Related]
10. Clinical developments in nanotechnology for cancer therapy.
Heidel JD; Davis ME
Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
[TBL] [Abstract][Full Text] [Related]
11. Development of NGR-based anti-cancer agents for targeted therapeutics and imaging.
Wang RE; Niu Y; Wu H; Hu Y; Cai J
Anticancer Agents Med Chem; 2012 Jan; 12(1):76-86. PubMed ID: 22023047
[TBL] [Abstract][Full Text] [Related]
12. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.
Shi D; Bedford NM; Cho HS
Small; 2011 Sep; 7(18):2549-67. PubMed ID: 21648074
[TBL] [Abstract][Full Text] [Related]
13. Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis.
Perumal V; Sivakumar PM; Zarrabi A; Muthupandian S; Vijayaraghavalu S; Sahoo K; Das A; Das S; Payyappilly SS; Das S
J Photochem Photobiol B; 2019 Oct; 199():111630. PubMed ID: 31610429
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
15. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
17. Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery.
Rijpkema M; Boerman OC; Oyen WJ
Curr Drug Targets; 2015; 16(6):625-33. PubMed ID: 25355181
[TBL] [Abstract][Full Text] [Related]
18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
19. [Molecular imaging in cancer therapy].
Weber WA
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780
[TBL] [Abstract][Full Text] [Related]
20. Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies.
Jang B; Kwon H; Katila P; Lee SJ; Lee H
Adv Drug Deliv Rev; 2016 Mar; 98():113-33. PubMed ID: 26654747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
